Related Experiment Video
Updated: May 24, 2026
06:18
Measurement of Myocardial Lactate Production for Diagnosis of Coronary Microvascular Spasm
Published on: September 17, 2021
Spontaneous coronary artery dissection during cabergoline therapy
Nishaki Kiran Mehta1, Samir Malkani, Ira Ockene
1Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts 01655, USA. nishaki@gmail.com
Texas Heart Institute Journal
|March 14, 2012
Summary
Spontaneous coronary artery dissection, a rare cause of chest pain, may be linked to the drug cabergoline. This case report suggests considering cabergoline
Area of Science:
- Cardiology
- Pharmacology
Background:
- Spontaneous coronary artery dissection (SCAD) is an uncommon cause of acute coronary syndrome.
- Coronary vasospasm is a potential precursor to SCAD.
- Cabergoline, a dopamine agonist, is known to induce digital vasospasm.
Observation:
- A 43-year-old woman developed spontaneous right coronary artery dissection.
- The patient was undergoing treatment for prolactinoma with cabergoline.
Findings:
- This case presents the first reported association between cabergoline therapy and SCAD.
- The findings suggest a potential link between cabergoline-induced vasospasm and coronary artery dissection.
Implications:
- Clinicians should consider cabergoline as a potential trigger for SCAD in patients presenting with chest pain.
- Further investigation into the cardiovascular risks of cabergoline, particularly coronary artery spasm, is warranted.
Related Concept Videos
01:19Depolarizing Blockers: Pharmocokinetics
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
01:28Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
01:11Direct-Acting Cholinergic Agonists: Therapeutic Uses
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren syndrome.
01:26Cushing Syndrome I: Introduction
Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...